# 3-AP in Treating Patients With Advanced Prostate Cancer

> **NCT00054015** · PHASE2 · COMPLETED · sponsor: **Vion Pharmaceuticals**

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** triapine

## Key facts

- **NCT ID:** NCT00054015
- **Lead sponsor:** Vion Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** —
- **Final completion:** 2008-01
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00054015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00054015, "3-AP in Treating Patients With Advanced Prostate Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00054015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*